论文信息 - 1067 Analysis of the EORTC Melanoma Group 18952 randomized trial on 2 intermediate dose schedules of IFN-alpha2b compared with observation in 1388 patients with high risk melanoma stages IIB-III - 字舞流文

1067 Analysis of the EORTC Melanoma Group 18952 randomized trial on 2 intermediate dose schedules of IFN-alpha2b compared with observation in 1388 patients with high risk melanoma stages IIB-III

A. Eggermont | A. Testori | C. Punt | G. Groenewegen | R. MacKie | P. Patel | W. Ruka | S. Suciu | M. Delaunay | F. Sales | W. Kruit | D. Liénard | K. Stoitchkov